Company Filing History:
Years Active: 1989-1991
Title: The Innovative Contributions of Chaur-Ming Jan
Introduction
Chaur-Ming Jan is a notable inventor based in Randolph, NJ (US). He has made significant contributions to the field of pharmaceuticals through his innovative inventions. With a total of 2 patents, Jan has demonstrated his expertise and creativity in developing solutions that enhance pharmaceutical processes.
Latest Patents
One of Jan's latest patents is the Dividable Capsule. This invention allows users to divide a capsule into accurate individual dosage units. The capsule consists of first and second cylindrical units that are detachably joined, ensuring that the longitudinal axes of both units are approximately co-linear. The units can be joined using adhesive, banding, or locking mechanical means, and the design allows for the possibility of multiple units.
Another significant patent is the Fluidized Bed Dryer/Granulator. This device is designed for coating pellets used in pharmaceutical material preparation. It features a chamber with a top wall and a bowl at the bottom, along with an axial air inlet that directs air flow through the chamber. Additionally, it includes removable air inlets that create a circumferential flow of air, enhancing the treatment rate of materials within the chamber.
Career Highlights
Chaur-Ming Jan has had a successful career at Warner-Lambert Company, where he has applied his innovative ideas to improve pharmaceutical manufacturing processes. His work has contributed to advancements in drug delivery systems and material treatment techniques.
Collaborations
Jan has collaborated with notable coworkers such as Frank W Goodhart and Mark E Oehling. Their combined expertise has fostered an environment of innovation and creativity within their projects.
Conclusion
Chaur-Ming Jan's contributions to the pharmaceutical industry through his patents and collaborative efforts highlight his role as a significant inventor. His work continues to influence the development of effective pharmaceutical solutions.